UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
SCHEDULE 13/A
Under the Securities Exchange Act of 1934
(Amendment No. 6)*
RHEOMETRICS SCIENTIFIC, INC.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
762073 10 4
(CUSIP Number)
Peter H, Ehrenberg, Esq.
Lowenstein, Sandler, Kohl, Fisher & Boylan
65 Livingston Avenue
Roseland, New Jersey 07068
(201) 992-8700
Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
May 3, 1996
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with this statement [ ]. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of less than five percent of such class.
See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule l3d-1(a) for other parties to whom copies are to be
sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No: 762073 10 4
1) Names of Reporting Persons: JOSEPH M. STARITA
(S.S. or I.R.S. Identification Nos. of Above Persons):
2) Check the Appropriate Box if a Member of a Group (See Instructions):
(a) [ ]
(b) [ ]
3) SEC Use Only
4) Source of Funds (See Instructions):
Not applicable
5) Check if Disclosure of Legal Proceedings is Required Pursuant
to Items 2(d) or 2(e): [ ]
6) Citizenship or Place of Organization:
United States
Number of 7) Sole Voting Power: 769,535
Shares Bene-
ficially 8) Shared Voting Power: 0
Owned by
Each Report- 9) Sole Dispositive Power: 769,535
ing Person
With: 10) Shared Dispositive Power: 0
11) Aggregate Amount Beneficially Owned by Each Reporting Person: 769,535
12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions) [ ]
13) Percent of Class Represented by Amount in Row (11): 5.84%
14) Type of Reporting Person: IN
This Amendment No. 6 amends the Schedule 13D (as previously amended by
Amendments 1 through 5 thereto) of Dr. Joseph Starita (the "Schedule 13D") by
changing the number of shares of Common Stock, no par value of Rheometrics
Scientific, Inc., previously reported as beneficially owned by Dr. Starita from
774,235 to 769,535. The previous number was reported in error due to the
inadvertant omission of two additional sales by Dr. Starita which sales are
reflected herein. Other than as amended hereby, the Schedule 13D is ratified and
confirmed in all reports.
<PAGE>
Item 1. Security and Issuer
This statement relates to the common stock, no par value ("Common
Stock"), of Rheometrics Scientific, Inc., a New Jersey corporation (the
"Company"). The address of the Company's principal executive offices is One
Possumtown Road, Piscataway, New Jersey 08854.
Item 2. Identity and Background
(a) This statement is being filed by Joseph M. Starita ("Dr.
Starita").
(b) Dr. Starita's home address is 16 Deerfield Court, Basking Ridge,
New Jersey 07920.
(c) Dr. Starita is currently a Senior Consultant to Stevens Institute
of Technology. Dr Starita is not employed by, and is neither a
director or officer of, the Company.
(d)(e) During the last five years, Dr. Starita has not been convicted in
a criminal proceeding (excluding traffic violations or similar
misdemeanors) or been a party to a civil proceeding of a judicial
or administrative body of competent jurisdiction and as a result
of such proceeding was or is subject to a judgment, decree, or
final order enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state securities laws
or finding any violation with respect to such laws.
(f) Dr. Starita is a citizen of the United States.
Item 3. Source and Amount of Funds or Other Consideration
Not applicable.
Item 4. Purpose of Transaction.
Dr. Starita has no present plans or proposals which relate to or would
result in any of the events referred to in items (a) through (j) of Item 4,
except that Dr. Starita may dispose of shares of Common Stock from time to time.
Item 5. Interest in Securities of the Issuer
(a) As of May 20, 1996, Dr. Starita owned beneficially 769,535 shares (the
"Shares") of Common Stock, representing approximately 5.84% of the outstanding
Common Stock.
(b) Dr. Starita has sole power to vote and sole power to dispose of the
Shares.
(c) During the past sixty days, Dr. Starita (i) sold 4,000 shares of Common
Stock on March 28, 1996 pursuant to a market transaction at a price of $1-13/16
per share, (ii) sold 1,000 shares of Common Stock on April 2, 1996 pursuant to a
market transaction at a price of $2-1/4 per share, (iii) sold 1,000 shares of
Common Stock on April 3, 1996 pursuant to a market transaction at a price of
$2-7/8 per share, (iv) transferred 780,236 shares of Common Stock to his former
wife on May 3, 1996 as a result of a divorce settlement and (v) sold an
aggregate of 4,700 shares of Common Stock on May 3, 1996 pursuant to market
transactions, 2,000 of which were sold at a price of $2-5/16 and 2,700 of which
were sold at a price of $2-7/16.
(d) Other than Dr. Starita, no person has the right to receive or the
power to direct the receipt of dividends from, or the proceeds from the sale
of, the Shares.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationship with Respect
to Securities of the Issuer.
None.
Item 7. Materials to be Filed as Exhibits.
None.
Signature
After reasonable inquiry, and to the best of the undersigned's
knowledge and belief, the undersigned hereby certifies that the information set
forth in this Amendment No. 6 is true, complete and correct.
/s/ Joseph M. Starita
_________________________________
Joseph M. Starita
Dated: ___________, 1996
ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL
CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001)
